Exicure (XCUR) EBITDA (2016 - 2026)
Exicure (XCUR) reported EBITDA of -$1.6 million for Q1 2026, down 156.11% on a YoY basis from $2.9 million in Q1 2025, and up 27.3% quarter-over-quarter from -$2.3 million in Q4 2025.
Exicure (XCUR) EBITDA (2016 - 2026) Analysis & Trends
Exicure has reported EBITDA for 11 years, with the latest figure at -$1.6 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA fell 156.11% year-over-year to -$1.6 million; the trailing twelve-month figure through Mar 2026 stood at -$8.8 million (down 3.81% YoY), and the FY2025 full-year result was -$4.2 million, up 65.39% from the prior year.
- EBITDA for Q1 2026 stood at -$1.6 million, up from -$2.3 million in the prior quarter.
- The five-year high for EBITDA was $18.6 million in Q4 2022, with the low at -$7.7 million in Q1 2022.
- Historically, EBITDA has averaged -$2.1 million across 5 years, with a median of -$2.5 million in 2025.
- Annual changes were most pronounced in 2024 — EBITDA sank 406.61% — and 2025, when it soared 449.64%.
- Exicure's EBITDA stood at $18.6 million in 2022, then plunged by 108.06% to -$1.5 million in 2023, then slumped by 406.61% to -$7.6 million in 2024, then soared by 70.27% to -$2.3 million in 2025, then grew by 27.3% to -$1.6 million in 2026.
- The last three EBITDA figures came in at -$1.6 million (Q1 2026), -$2.3 million (Q4 2025), and -$2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -65.83 Mn |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | -1.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.64 Mn |
| Dec 31, 2025 | -2.26 Mn |
| Sep 30, 2025 | -2.39 Mn |
| Jun 30, 2025 | -2.51 Mn |
| Mar 31, 2025 | 2.92 Mn |
| Dec 31, 2024 | -7.59 Mn |
| Sep 30, 2024 | -2.57 Mn |
| Jun 30, 2024 | -1.24 Mn |
| Mar 31, 2024 | -836,000.00 |
| Dec 31, 2023 | -1.50 Mn |
| Sep 30, 2023 | -3.32 Mn |
| Jun 30, 2023 | -5.64 Mn |
| Mar 31, 2023 | -4.54 Mn |
| Dec 31, 2022 | 18.59 Mn |
| Sep 30, 2022 | -5.21 Mn |
| Jun 30, 2022 | -7.48 Mn |
| Mar 31, 2022 | -7.74 Mn |
| Dec 31, 2021 | -13.45 Mn |
| Sep 30, 2021 | -23.08 Mn |
| Jun 30, 2021 | -13.86 Mn |